Efficiently Targeting Metastatic Osteosarcoma, Neuroblastoma and Glioblastoma with Ex-Vivo Expanded Natural Killer Cells Combined with N-803 (ALT-803, IL-15 Superagonist) and TIM-3 Blockage

Authors

Yaya Chu, New York Medical CollegeFollow
Jeremy RosenblumFollow
Emily K. Jeng
Sarah AlterFollow
Peter R. Rhode
John H. LeeFollow
Dean LeeFollow
Wong C. Hing
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

3-2019

DOI

10.1016/j.bbmt.2018.12.543

Journal Title

Biology of Blood and Marrow Transplantation

Department

Pediatrics

Second Department

Health Behavior and Community Health

Disciplines

Medicine and Health Sciences

Recommended Citation

Chu, Y., Rosenblum, J., Jeng, E. K., Alter, S., Rhode, P. R., Lee, J. H., Lee, D., Hing, W. C., & Cairo, M. S. (2019). Efficiently Targeting Metastatic Osteosarcoma, Neuroblastoma and Glioblastoma with Ex-Vivo Expanded Natural Killer Cells Combined with N-803 (ALT-803, IL-15 Superagonist) and TIM-3 Blockage. Biology of Blood and Marrow Transplantation, 25 (3 Suppl.1), S336. https://doi.org/10.1016/j.bbmt.2018.12.543